Gene · 9
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of Extracellular Vesicles From Multiple Cells on Vascular Smooth Muscle Cells in Atherosclerosis. | Front Pharmacol | 2022 | 35620296 | PubTator, text mining | PubMed |
| Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases. | Cancer Lett | 2022 | 35589002 | PubTator, text mining | PubMed |
| The role of arylamine N-acetyltransferases in chronic degenerative diseases: Their possible function in the immune system. | Biochim Biophys Acta Mol Cell Res | 2022 | 35588943 | PubTator, text mining | PubMed |
| Synthesis and target annotation of the alkaloid GB18. | Nature | 2022 | 35551513 | PubTator, text mining | PubMed |
| Disinfection By-Products in Drinking Water and Bladder Cancer: Evaluation of Risk Modification by Common Genetic Polymorphisms in Two Case-Control Studies. | Environ Health Perspect | 2022 | 35536285 | PubTator, text mining | PubMed |
| Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives. | Acta Pharm Sin B | 2022 | 35530147 | PubTator, text mining | PubMed |
| Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents. | Evid Based Complement Alternat Med | 2022 | 35509623 | PubTator, text mining | PubMed |
| Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021. | Front Pharmacol | 2022 | 35496282 | PubTator, text mining | PubMed |
| Polymorphism association of NIL1, NIL2, CYP1A1 xenobiotic metabolism genes and their expression with the risk of colorectal cancer in the Polish population. | Pol Przegl Chir | 2022 | 35485310 | PubTator, text mining | PubMed |
| The paradigm of drug resistance in cancer: an epigenetic perspective. | Biosci Rep | 2022 | 35438143 | PubTator, text mining | PubMed |
| Luteolin Causes 5'CpG Demethylation of the Promoters of TSGs and Modulates the Aberrant Histone Modifications, Restoring the Expression of TSGs in Human Cancer Cells. | Int J Mol Sci | 2022 | 35409426 | PubTator, text mining | PubMed |
| Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem. | Cancers (Basel) | 2022 | 35406495 | PubTator, text mining | PubMed |
| Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus Treatment Towards Personalized Medicine. | Front Pharmacol | 2022 | 35370680 | PubTator, text mining | PubMed |
| Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population. | Hum Genomics | 2022 | 35366956 | PubTator, text mining | PubMed |
| Polymorphism in the human arylamine N-acetyltransferase 1 gene 3'-untranslated region determines polyadenylation signal usage. | Biochem Pharmacol | 2022 | 35358480 | PubTator, text mining | PubMed |
| Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells. | Toxicol Appl Pharmacol | 2022 | 35353990 | PubTator, text mining | PubMed |
| Identification of critical residues of O-antigen-modifying O-acetyltransferase B (OacB) of Shigella flexneri. | BMC Mol Cell Biol | 2022 | 35331134 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development. | Cancer Med | 2022 | 35285582 | PubTator, text mining | PubMed |
| Human N-Acetyltransferase 1 and 2 Differ in Affinity Towards Acetyl-Coenzyme A Cofactor and N-Hydroxy-Arylamine Carcinogens. | Front Pharmacol | 2022 | 35281898 | PubTator, text mining | PubMed |
| The association between meat and fish intake by preparation methods and breast cancer in the Carolina Breast Cancer Study (CBCS). | Breast Cancer Res Treat | 2022 | 35275284 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9/papers?page=11